Australia markets close in 5 hours 24 minutes

Sonendo, Inc. (SONX)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
2.5300-0.0300 (-1.17%)
At close: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close2.5600
Open2.5400
Bid2.2000 x 800
Ask3.1300 x 1800
Day's range2.4000 - 2.6000
52-week range0.8600 - 6.8400
Volume35,102
Avg. volume281,904
Market cap125.884M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Sonendo Unveils New Branding and Website; Champions Clinicians Performing Root Canal Treatment

    LAGUNA HILLS, Calif., January 17, 2023--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced the launch of its new brand campaign and website. The updated branding is designed to reflect Sonendo’s ongoing commitment to investing in the specialty of endodontics and providing clinicians with the technology and resources they need to elevate patient care. With a modern and forward-looking quality to it, the campaign aims to bring a

  • Business Wire

    PIPStek LLC, a Subsidiary of Sonendo, Files Patent Infringement Lawsuit Against BIOLASE

    LAGUNA HILLS, Calif., January 04, 2023--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that its subsidiary PIPStek LLC has filed a patent infringement lawsuit against BIOLASE, Inc. in the U.S. District Court for the District of Delaware. In the lawsuit, PIPStek asserts infringement of PIPStek’s US patents 11,426,239 and 11,350,993 by BIOLASE’s Waterlase laser.

  • Business Wire

    Sonendo Celebrates One Million GentleWave® Procedures; Further Solidifies Its Position in Elevating the Patient Experience for Root Canal Treatment

    LAGUNA HILLS, Calif., December 06, 2022--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that more than one million patients have now been treated with the GentleWave Procedure since the system entered the commercial market. Redefining the standard of care for root canal therapy, the GentleWave Procedure offers a minimally invasive process that preserves tooth structure and promotes fast healing. A testament to the continue